{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:29:38Z","timestamp":1787671778419,"version":"build-2736575974"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"16","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["J Am Acad Orthop Surg","JAAOS"],"published-print":{"date-parts":[[2025,8,15]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Patients with type II diabetes mellitus (T2DM) are known to have inferior postoperative outcomes after open reduction and internal fixation (ORIF) of ankle fractures. Semaglutide (the active agent in Ozempic) has encouragingly been associated with improved postoperative outcomes across multiple elective orthopaedic surgeries; however, this has not been assessed for patients with T2DM undergoing ankle fracture ORIF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      Adult patients with T2DM who underwent ankle fracture ORIF were identified from the 2010\u2013Q1 2023 PearlDiver M170Ortho database. Exclusion criteria included the following: age younger than 18, high-energy injury mechanisms, concomitant tibial plafond fracture, other non-ankle traumatic injuries, neoplastic or infectious diagnoses within 30 days preoperatively, and those with &lt;90 days of follow-up. Patients with T2DM who used semaglutide within 1 year before ankle fracture ORIF were identified and matched 1:1 with patients with T2DM who had not used semaglutide based on age, sex, Elixhauser Comorbidity Index, end-organ diabetes complications, obesity (body mass index &lt;30 vs. &gt;30), insulin use, metformin use, sodium-glucose cotransport-2 inhibitor use, and insurance plan. The odds of 90-day adverse events were compared by multivariable logistic regression controlling for age, sex, and Elixhauser Comorbidity Index. Bonferroni correction of\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.005 was used to reduce the risk of type I error.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Among patients with T2DM undergoing ankle fracture ORIF, semaglutide use was noted for 2,700 patients (2.73%). After matching, there were 804 (+)semaglutide and 804 (\u2212)semaglutide patients. On multivariable analysis, (+)semaglutide patients had significantly lower odds of 90-day deep vein thrombosis (odds ratio [OR] 0.24), myocardial infarction (OR 0.34), surgical site infection (OR 0.30), sepsis (OR 0.38), pneumonia (OR 0.27), urinary tract infection (OR 0.27), wound dehiscence (OR 0.31), and emergency department visit (OR 0.45;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001 for all).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This study found reductions in 90-day cardiovascular and infectious complications after ORIF of ankle fractures for patients with T2DM using semaglutide preoperatively as part of their glycemic control regimen.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Level of Evidence:<\/jats:title>\n                    <jats:p>Level III<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5435\/jaaos-d-25-00439","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T16:00:15Z","timestamp":1750694415000},"page":"e971-e978","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Reduced 90-Day Cardiovascular and Infectious Complications After Open Reduction Internal Fixation of Ankle Fractures in Type II Diabetic Patients Using Semaglutide Preoperatively"],"prefix":"10.5435","volume":"33","author":[{"given":"Anthony E.","family":"Seddio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv S.","family":"Vasudevan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anshu","family":"Jonnalagadda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Slevin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2626-7278","authenticated-orcid":false,"given":"Jonathan N.","family":"Grauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brianna R.","family":"Fram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,6,17]]},"reference":[{"key":"R1-20250801","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1053\/j.jfas.2019.09.016","article-title":"Ankle fracture epidemiology in the United States: Patient-related trends and mechanisms of injury","volume":"59","author":"Scheer","year":"2020","journal-title":"J Foot Ankle Surg"},{"key":"R2-20250801","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1186\/s12891-022-06095-x","article-title":"Incidence, costs and post-operative complications following ankle fracture\u2014A US claims database analysis","volume":"23","author":"Vanderkarr","year":"2022","journal-title":"BMC Musculoskelet Disord"},{"key":"R3-20250801","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1053\/j.jfas.2020.03.026","article-title":"The operative treatment of ankle fractures: A 10-year retrospective study of 1529 patients","volume":"60","author":"Fenelon","year":"2021","journal-title":"J Foot Ankle Surg"},{"key":"R4-20250801","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S8756-3282(02)00832-3","article-title":"Increasing number and incidence of low-trauma ankle fractures in elderly people: Finnish statistics during 1970-2000 and projections for the future","volume":"31","author":"Kannus","year":"2002","journal-title":"Bone"},{"key":"R5-20250801","doi-asserted-by":"crossref","first-page":"e024067","DOI":"10.1136\/bmjopen-2018-024067","article-title":"Diabetes mellitus and the risk of fractures at specific sites: A meta-analysis","volume":"9","author":"Wang","year":"2019","journal-title":"BMJ Open"},{"key":"R6-20250801","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.2106\/JBJS.G.01673","article-title":"The management of ankle fractures in patients with diabetes","volume":"90","author":"Wukich","year":"2008","journal-title":"J Bone Joint Surg Am"},{"key":"R7-20250801","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1053\/j.jfas.2018.09.023","article-title":"Increased rates of readmission, reoperation, and mortality following open reduction and internal fixation of ankle fractures are associated with diabetes mellitus","volume":"58","author":"Liu","year":"2019","journal-title":"J Foot Ankle Surg"},{"key":"R8-20250801","doi-asserted-by":"crossref","first-page":"661","DOI":"10.5435\/JAAOS-D-19-00545","article-title":"Effects of diabetes mellitus on functional outcomes and complications after torsional ankle fracture","volume":"28","author":"Schmidt","year":"2020","journal-title":"J Am Acad Orthop Surg"},{"key":"R9-20250801","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1177\/10711007241250005","article-title":"Effect of elevated blood glucose on postoperative complications among diabetic patients after surgical treatment of torsional ankle fracture","volume":"45","author":"Chen","year":"2024","journal-title":"Foot Ankle Int"},{"key":"R10-20250801","doi-asserted-by":"crossref","first-page":"813","DOI":"10.7326\/M20-2470","article-title":"Pharmacologic approaches to glycemic treatment of type 2 diabetes: Synopsis of the 2020 American Diabetes Association's Standards of Medical Care in Diabetes Clinical Guideline","volume":"173","author":"Doyle-Delgado","year":"2020","journal-title":"Ann Intern Med"},{"key":"R11-20250801","doi-asserted-by":"crossref","first-page":"101102","DOI":"10.1016\/j.molmet.2020.101102","article-title":"GLP-1 receptor agonists in the treatment of type 2 diabetes\u2014state-of-the-art","volume":"46","author":"Nauck","year":"2021","journal-title":"Mol Metab"},{"key":"R12-20250801","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1016\/j.arth.2023.05.071","article-title":"Does semaglutide use decrease complications and costs following total knee arthroplasty?","volume":"38","author":"Magruder","year":"2023","journal-title":"J Arthroplasty"},{"key":"R13-20250801","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1016\/j.arth.2024.05.079","article-title":"Decreased risk of readmission and complications with preoperative GLP-1 analog use in patients undergoing primary total joint arthroplasty","volume":"39","author":"Buddhiraju","year":"2024","journal-title":"J Arthroplasty"},{"issue":"3","key":"R14-20250801","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.jseint.2024.10.006","article-title":"Improved total shoulder arthroplasty outcomes associated with semaglutide utilization in patients with type II diabetes: A promising new addition to preoperative optimization","volume":"9","author":"Seddio","year":"2025","journal-title":"JSES Int"},{"key":"R15-20250801","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.arth.2023.12.023","article-title":"Semaglutide use prior to total hip arthroplasty results in fewer postoperative prosthetic joint infections and readmissions","volume":"39","author":"Magruder","year":"2024","journal-title":"J Arthroplasty"},{"key":"R16-20250801","doi-asserted-by":"crossref","first-page":"e24.00148","DOI":"10.5435\/JAAOSGlobal-D-24-00148","article-title":"Glucagon-like peptide-1 agonists in total hip arthroplasty: Complications, readmissions, and patient-reported outcomes","volume":"8","author":"Magaldi","year":"2024","journal-title":"JAAOS Glob Res Rev"},{"key":"R17-20250801","doi-asserted-by":"crossref","DOI":"10.1016\/j.arth.2025.03.012","article-title":"GLP-1 agonists for weight loss: Do they increase complications in non-diabetic patients undergoing primary total hip arthroplasty?","author":"Verhey","year":"2025","journal-title":"J Arthroplasty"},{"key":"R18-20250801","doi-asserted-by":"crossref","DOI":"10.1097\/BRS.0000000000005283","article-title":"GLP-1 receptor agonist medications alter outcomes of spine surgery: A study among over 15,000 patients","author":"Wiener","year":"2025","journal-title":"Spine"},{"key":"R19-20250801","article-title":"Perioperative glucagon-like peptide-1 agonist use and rates of pseudarthrosis after single-level lumbar fusion: A large retrospective cohort study","author":"Agrawal","year":"2024","journal-title":"Neurosurgery"},{"issue":"3","key":"R20-20250801","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.spinee.2024.10.011","article-title":"Semaglutide utilization associated with reduced ninety-day postoperative complications following single-level posterior lumbar fusion for patients with type II diabetes","volume":"25","author":"Seddio","year":"2025","journal-title":"Spine J"},{"key":"R21-20250801","article-title":"Patients on antidepressants are at an increased risk of adverse events following total knee arthroplasty","author":"Ratnasamy","year":"2024","journal-title":"J Am Acad Orthop Surg"},{"key":"R22-20250801","doi-asserted-by":"crossref","first-page":"e445","DOI":"10.5435\/JAAOS-D-22-00917","article-title":"Incidental durotomy after posterior lumbar decompression surgery associated with increased risk for venous thromboembolism","volume":"31","author":"Gouzoulis","year":"2023","journal-title":"The J Am Acad Orthopaedic Surgeons"},{"key":"R23-20250801","doi-asserted-by":"crossref","first-page":"265","DOI":"10.5435\/JAAOS-D-23-00365","article-title":"Lumbar laminotomy: Variables affecting 90-day overall reimbursement","volume":"32","author":"Halperin","year":"2024","journal-title":"J Am Acad Orthop Surg"},{"key":"R24-20250801","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1097\/MLR.0b013e31819432e5","article-title":"A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data","volume":"47","author":"van Walraven","year":"2009","journal-title":"Med Care"},{"key":"R25-20250801","doi-asserted-by":"crossref","first-page":"601","DOI":"10.2106\/JBJS.20.01535","article-title":"Metformin use is associated with fewer complications in patients with type-2 diabetes undergoing total knee arthroplasty: A propensity score-matched analysis","volume":"103","author":"Wilson","year":"2021","journal-title":"J Bone Joint Surg Am"},{"key":"R26-20250801","first-page":"10.18553\/jmcp.2021.27.4.455","article-title":"Cost-effectiveness of oral semaglutide added to current antihyperglycemic treatment for type 2 diabetes","volume":"27","author":"Guzauskas","year":"2021","journal-title":"J Manag Care Spec Pharm"},{"key":"R27-20250801","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.fas.2022.03.009","article-title":"Clinical outcomes in the surgical management of ankle fractures: A systematic review and meta-analysis of fibular intramedullary nail fixation vs. open reduction and internal fixation in randomized controlled trials","volume":"28","author":"Walsh","year":"2022","journal-title":"Foot Ankle Surg"},{"key":"R28-20250801","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1053\/j.jfas.2019.06.005","article-title":"Functional outcomes following operative and nonoperative management of weber C ankle fractures: A systematic review","volume":"59","author":"Yap","year":"2020","journal-title":"J Foot Ankle Surg"},{"key":"R29-20250801","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.injury.2017.11.006","article-title":"Diabetes and healing outcomes in lower extremity fractures: A systematic review","volume":"49","author":"Gortler","year":"2018","journal-title":"Injury"},{"key":"R30-20250801","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.2040-1124.2010.00070.x","article-title":"Mechanism of diabetic neuropathy: Where are we now and where to go?","volume":"2","author":"Yagihashi","year":"2011","journal-title":"J Diabetes Investig"},{"key":"R31-20250801","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.3390\/jcm10112419","article-title":"Effects of hyperglycemia and diabetes mellitus on coagulation and hemostasis","volume":"10","author":"Li","year":"2021","journal-title":"J Clin Med"},{"key":"R32-20250801","doi-asserted-by":"crossref","first-page":"944506","DOI":"10.3389\/fcvm.2022.944506","article-title":"Hyperglycemia may increase deep vein thrombosis in trauma patients with lower limb fracture","volume":"9","author":"Liu","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"R33-20250801","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.2106\/JBJS.K.00193","article-title":"Relationship of hyperglycemia and surgical-site infection in orthopaedic surgery","volume":"94","author":"Richards","year":"2012","journal-title":"J Bone Joint Surg Am"},{"key":"R34-20250801","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s11892-021-01434-z","article-title":"Managing patients undergoing orthopedic surgery to improve glycemic outcomes","volume":"21","author":"Diaz","year":"2022","journal-title":"Curr Diab Rep"},{"key":"R35-20250801","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.2106\/JBJS.22.00149","article-title":"Perioperative identification and management of hyperglycemia in orthopaedic surgery","volume":"104","author":"Lamanna","year":"2022","journal-title":"J Bone Joint Surg Am"},{"key":"R36-20250801","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"R37-20250801","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"key":"R38-20250801","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2147\/DMSO.S67400","article-title":"Mechanism linking diabetes mellitus and obesity","volume":"7","author":"Al-Goblan","year":"2014","journal-title":"Diabetes Metab Syndr Obes"},{"key":"R39-20250801","doi-asserted-by":"crossref","first-page":"106320","DOI":"10.1016\/j.phrs.2022.106320","article-title":"The anti-inflammatory and immunological properties of GLP-1 Receptor Agonists","volume":"182","author":"Bendotti","year":"2022","journal-title":"Pharmacol Res"},{"key":"R40-20250801","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/apt.15316","article-title":"Effect of semaglutide on liver enzymes and markers of inflammation in subjects with type 2 diabetes and\/or obesity","volume":"50","author":"Newsome","year":"2019","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Journal of the American Academy of Orthopaedic Surgeons"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.5435\/JAAOS-D-25-00439","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:49:23Z","timestamp":1787669363000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.5435\/JAAOS-D-25-00439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,17]]},"references-count":40,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.5435\/jaaos-d-25-00439","relation":{},"ISSN":["1067-151X","1940-5480"],"issn-type":[{"value":"1067-151X","type":"print"},{"value":"1940-5480","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,17]]},"assertion":[{"value":"2025-04-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-03","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}